|Best Practice || > About > Best Practice
The PEMJ is operated according to the Principles of Transparency and Best Practice in Scholarly Publishing 3rd ed (https://publicationethics.org/resources/guidelines-new/principles-transparency-and-best-practice-scholarly-publishing).
||Website (aim and scope, authorship)
||Pediatric Emergency Medicine Journal, Pediatr Emerg Med J; pISSN 2383-4897, eISSN 2508-5506.
||PEMJ aims at pediatricians, emergency physicians, and other 0health care providers who are interested in pediatric emergency medicine. The journal focuses on both basic and clinical research of pediatric emergency medicine such as pathophysiology, epidemiology, diagnosis, prognosis, treatment, and simulation. PEMJ accepts original articles, reviews, editorials, case reports, brief communications, correspondences, and special contributions.
||Name of journal
||Peer review process
- 1. The submitted manuscript will first be evaluated at the editorial board regarding the possibility of plagiarism, completeness of the submitted materials, and their suitability to PEMJ. Prior to the peer review, the editorial board can reject manuscripts for misconduct, or request the authors for explanation. Manuscripts may be returned to the authors at this stage if they have serious flaws or are not suitable for PEMJ.
- 2. Submitted manuscripts will generally be reviewed by the editors and two peer reviewers. The reviewers make suggestions to the editorial board.
- 3. PEMJ performs double-blinded peer review of the submitted manuscripts. Neither the peer reviewers nor the authors are revealed to each other. Authors may suggest preferred reviewers. However, this suggestion may not be accepted by the editorial board.
- 4. The authors can monitor the progress of the manuscript throughout the review process at the submission system (https://submit.pemj.org).
- 5. The first review is finished within 60 days after the first submission. Reviewers consider the originality, scientific importance, study design, methodology, brevity in expression, priority for publication, and potential for revision. Reviewers should provide constructive criticism on the parts requiring revision. Submitted manuscripts will be rendered one of the following decisions: Accept, Minor Revisions, Major Revisions, and Reject. A revision needs to be submitted within 60 days of the decision. Otherwise, the manuscript is regarded as a new submission.
- 1) All submitted manuscripts are subject to the Crosscheck, and the editorial office can reject the manuscripts suspected of plagiarism.
- 2) Manuscripts for case reports regarding diseases that have already been reported cannot be published. However, they may be published after proper review process if they contain the discussion over unknown aspects of the disease, new diagnostic and therapeutic modalities, and unknown associated diseases.
- 3) If manuscripts regarding drugs or equipment have a potential for commercial use, the editorial office can consult proper specialists on them.
- 4) Manuscripts containing the contents which have already been rejected by PEMJ can be published only if substantially improved.
- 5) The editorial board reserves the right to make corrections to literary and technical flaws found in the accepted manuscripts after proper communication with the corresponding authors.
- 6) The editorial board can refer the editing process to outsourced manuscript editors.
- 6. The decision to accept a manuscript is not based solely on the scientific validity and originality; other factors are considered, including the extent and importance of new information in the paper as compared with that in other papers being considered, the journal's need to represent a wide range of topics, the overall suitability for PEMJ, and research and publication ethics.
- 7. Decision letters usually, but not always, convey all factors considered for a particular decision. Occasionally, reviewers’ comments may appear to be inconsistent with the decision, which takes into consideration reviewers' comments as well as the additional factors listed above.
||Ownership and management
||The Pediatric Emergency Medicine Journal (Pediatr Emerg Med J, PEMJ; pISSN 2383-4897, eISSN 2508-5506) is the official peer-reviewed journal of the Korean Society of Pediatric Emergency Medicine (KSPEM). The KSPEM holds the copyright on all submitted articles
||Editorial team/contact information
||Copyright and Licensing
||Copyrights of all published materials are owned by the KSPEM and must not be published elsewhere without written permission. The form of copyright transfer form is available from the journal website and submission system
||All articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/license/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
||Since July 1, 2019, authors are required to pay APC of 200 USD (200,000 KRW) upon the acceptance. They are also charged for color printing of figures unless the printing is considered necessary by the editorial board (e.g., endoscopic finding, skin lesion or pathology). PEMJ does not provide reprint service.
||Process for identification of and dealing with allegations of research misconduct
||When the editorial board faces suspected cases of research and publication misconduct such as duplicate publication, plagiarism, fraudulent or fabricated data, changes in authorship, undisclosed conflicts of interest, ethical problem, a reviewer who has appropriated an author’s idea or data, complaints against editors, and etc., the resolving process will follow the flowchart provided by COPE
(http://publicationethics.org/resources/flowcharts). The Research and Publication Ethics Subcommittee makes a decision on suspected cases. In this process, a debatable matter may be consulted to KAMJE.
||It is to be published biannually, on June 30 and December 31.
||The PEMJ is freely distributed to members of the KSPEM and relevant institutions. Full text files are also freely available at the official (https://www.pemj.org) and mobile ( pemj.org/m) websites. For subscription, please contact us.
||The journal is accessible at KoreaMed (https://koreamed.org), Synapse (https://synapse.koreamed.org), KMbase (https://kmbase.medric.or.kr), Korea Citation Index (https://www.kci.go.kr/kciportal/main.kci), Google Scholar (https://scholar.google.co.kr), and National Library of Korea (http://nl.go.kr) in the event the journal is no longer published.
||Revenue sources of the journal include APC, financial support from the KSPEM, advertisement, and the governmental funds.
||Academic contents and editorial decisions of the PEMJ are independent from commercial interests or specific contracts with advertisers. The journal reserves the right to decline any type of advertising that is harmful to the value of the journal. Advertisements should clearly identify the advertiser and the product or service being offered. Exaggerated copy is not allowed. PEMJ do not allow any specific advertisements to be linked to specific articles, of which contents are related to the products being advertised.
||Journal propagation has been done through the journal website and distribution of the journals. Invitations to submit a manuscript are usually focused on the members of the relevant societies, presenters at conferences, seminars or workshops if the topic is relevant to the aims and scope.